Would patient selection based on both calcitonin blood level and doubling time improve 18F-FDG PET sensitivity in restaging of medullary thyroid cancer? uri icon

Overview

publication date

  • September 1, 2007

Research

keywords

  • Calcitonin
  • Carcinoma, Medullary
  • Fluorodeoxyglucose F18
  • Radiopharmaceuticals
  • Thyroid Neoplasms

Identity

Scopus Document Identifier

  • 34548599812

Digital Object Identifier (DOI)

  • 10.2967/jnumed.107.044248

PubMed ID

  • 17785732

Additional Document Info

volume

  • 48

issue

  • 9